SFES has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SFES has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Research & Development is the aggregate amount of research and development expenses during the year. Safeguard Scientifics's Research & Development for the three months ended in Dec. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.
The historical data trend for Safeguard Scientifics's Research & Development can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Safeguard Scientifics Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Research & Development | Get a 7-Day Free Trial | - | - | - | - | - |
Safeguard Scientifics Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Research & Development | Get a 7-Day Free Trial | - | - | - | - | - |
This is the expense the company spent on research and development.
Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Safeguard Scientifics (OTCPK:SFES) Research & Development Explanation
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Thank you for viewing the detailed overview of Safeguard Scientifics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.
Satterfield Thomas A Jr | 10 percent owner | 2609 CALDWELL MILL LN, BIRMINGHAM AL 35243 |
Beth Michelson | director | C/O CARTESIAN GROWTH CORPORATION II, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017 |
Ross D Demont | director | 51 PICKWICK ROAD, NEWTON MA 02465 |
Manko Joseph M. Jr. | director | 1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103 |
Bob Rosenthal | director | 20 NEWBURY ST, BOSTON MA 02116 |
Mark Herndon | officer: SVP & Chief Financial Officer | C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087 |
Eric Salzman | officer: Chief Restructuring Officer | C/O 8X8 INC., 675 CREEKSIDE WAY, CAMPCALL CA 95008 |
Ira M Lubert | director | C/O PENN. REAL ESTATE INVESTMENT TRUST, 200 S. BROAD ST., THE BELLEVUE, PHILADEPHIA PA 19102 |
John Joseph Roberts | director | 1007 CANTERBURY LANE, VILLANOVA PA 19085 |
Brian J Sisko | officer: Senior V.P. & General Counsel | 435 DEVON PARK DRIVE, BUILDING 800, WAYNE PA 19087 |
Russell D Glass | director | 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087 |
David A Kille | officer: Senior VP & CFO | C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087 |
Maureen F Morrison | director | C/O ASBURY AUTOMOTIVE GROUP, 2905 PREMIERE PKWY, STE 300, DULUTH GA 30097 |
Stephen T Zarrilli | officer: Acting Sr VP & Acting CFO | FIBERLINK COMMUNICATIONS CORP., 794 PENLLYN PIKE, BLUE BELL PA 19422 |
Andrew E Lietz | director | P O BOX 738, RYE NH 03870 |
From GuruFocus
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.